Today's trade is in a company that is a global pharmaceutical company focused on making medicines widely available and affordable. What's not to love about that?
Want more to love? The company IPO'd in late 2020, naturally printed it's all-time high soon after (just shy of $19 per share), and after basing for 5-years, looks like it's finally ready to break into new all-time highs. The real ones.
You need to have a subscription to access this content in full.
Log in or subscribe today to unlock new features and receive Member Benefits.
